---
figid: PMC5341220__BPH-172-5239-g002
figtitle: Canonical signalling pathways activated by the EP receptors
organisms:
- NA
pmcid: PMC5341220
filename: BPH-172-5239-g002.jpg
figlink: /pmc/articles/PMC5341220/figure/bph13331-fig-0002/
number: F2
caption: Canonical signalling pathways activated by the EP receptors. The EP receptors
  are high‐affinity GPCRs characterized by the activation of different signalling
  pathways. (A) EP1 receptors couple to Gαq protein and mediate signalling events
  by activation of PLC. This results in the elevation of cytoplasmic signalling intermediates
  including IP3 and DAG, an increase in intracellular Ca2+, leading to the activation
  of PKC. (B) and (C) EP2 and EP4 receptors are linked to Gαs proteins and function
  by inducing the adenylate cyclase (AC) system, increasing the level of the secondary
  messenger cAMP and activating PKA. The receptors can also activate the PI3K signalling
  pathway by phosphorylation induced by GPCR kinases. This ultimately results in the
  triggering of NF‐κB‐mediated transcription programmes. (D) The EP3 receptors are
  unique in their ability to couple to multiple G proteins. Activation of Gi proteins
  results in the inhibition of adenylate cyclase, whereas signalling through Gs results
  in cAMP production. EP3 receptors can also be coupled to G12/13 proteins, resulting
  in the activation of the small G protein Rho.
papertitle: 'Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic
  targets?.'
reftext: G O'Callaghan, et al. Br J Pharmacol. 2015 Nov;172(22):5239-5250.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9777129
figid_alias: PMC5341220__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5341220__F2
ndex: bddad9f7-deb3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5341220__BPH-172-5239-g002.html
  '@type': Dataset
  description: Canonical signalling pathways activated by the EP receptors. The EP
    receptors are high‐affinity GPCRs characterized by the activation of different
    signalling pathways. (A) EP1 receptors couple to Gαq protein and mediate signalling
    events by activation of PLC. This results in the elevation of cytoplasmic signalling
    intermediates including IP3 and DAG, an increase in intracellular Ca2+, leading
    to the activation of PKC. (B) and (C) EP2 and EP4 receptors are linked to Gαs
    proteins and function by inducing the adenylate cyclase (AC) system, increasing
    the level of the secondary messenger cAMP and activating PKA. The receptors can
    also activate the PI3K signalling pathway by phosphorylation induced by GPCR kinases.
    This ultimately results in the triggering of NF‐κB‐mediated transcription programmes.
    (D) The EP3 receptors are unique in their ability to couple to multiple G proteins.
    Activation of Gi proteins results in the inhibition of adenylate cyclase, whereas
    signalling through Gs results in cAMP production. EP3 receptors can also be coupled
    to G12/13 proteins, resulting in the activation of the small G protein Rho.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ca
  - norpA
  - sl
  - Plc21C
  - gas
  - Galphas
  - gd
  - tRNA:Glu-CTC-1-1
  - tRNA:Glu-CTC-3-9
  - tRNA:Glu-CTC-2-2
  - tRNA:Glu-CTC-3-6
  - tRNA:Glu-CTC-3-3
  - tRNA:Glu-CTC-3-8
  - tRNA:Glu-CTC-3-4
  - tRNA:Glu-CTC-3-5
  - tRNA:Glu-CTC-3-2
  - tRNA:Glu-CTC-2-3
  - tRNA:Glu-CTC-3-1
  - tRNA:Glu-CTC-2-1
  - tRNA:Glu-CTC-3-7
  - ATPsynbeta
  - Atpalpha
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Axn
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - arm
  - sgg
  - CrebB
  - CrebA
  - Dif
  - dl
  - Rel
  - NFAT
  - MKP-4
  - p38b
  - rl
  - Rho1
  - gskt
  - Raf
  - PTGER2
  - SPAG11B
  - PTGER1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - GAST
  - GALNS
  - PAGR1
  - ATP8A2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - AXIN1
  - AXIN2
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CTNNB1
  - GSK3A
  - GSK3B
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTGER4
  - PTGER3
  - ATF6B
  - GNA13
  - GNA12
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - RHOA
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - EGR1
  - PGE
  - Cancer
---
